Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-25 Tax Withholding | 2025-02-26 5:33 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 507 | $0.9561 | 315,538 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:33 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 149,180 | $0 | 315,538 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:33 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 705 | $1 | 315,538 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,513 | $0.9561 | 1,393,405 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:32 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 680,000 | $0 | 1,393,405 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,792 | $1 | 1,393,405 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,375 | $0.9561 | 1,374,842 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:32 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 680,000 | $0 | 1,374,842 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:32 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,434 | $1 | 1,374,842 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:31 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,375 | $0.9561 | 1,371,803 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:31 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 680,000 | $0 | 1,371,803 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:31 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,792 | $1 | 1,371,803 (Direct) | View |
| 2025-02-25 Tax Withholding | 2025-02-26 5:30 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 10,663 | $0.9561 | 4,202,848 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-26 5:30 pm | N/A 2035-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 2,125,000 | $0 | 4,202,848 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 5:30 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 7,488 | $1 | 4,202,848 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 30,456 | $1.15 | 167,570 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 129,593 | $1.15 | 716,710 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 129,549 | $1.15 | 697,651 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 129,242 | $1.15 | 694,970 (Direct) | View |
| 2025-01-22 Tax Withholding | 2025-01-24 4:05 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 412,584 | $1.15 | 2,095,999 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:10 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 505 | $1.94 | 201,863 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:10 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 721 | $1.88 | 201,863 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:09 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,371 | $1.94 | 827,200 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:09 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 1,430 | $1.88 | 827,200 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,508 | $1.94 | 841,303 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 1,787 | $1.88 | 841,303 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,371 | $1.94 | 824,212 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 1,787 | $1.88 | 824,212 (Direct) | View |
| 2024-11-25 Tax Withholding | 2024-11-26 4:07 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 10,642 | $1.94 | 2,508,583 (Direct) | View |
| 2024-11-24 Tax Withholding | 2024-11-26 4:07 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 7,473 | $1.88 | 2,508,583 (Direct) | View |
Ownership | 2024-10-28 4:11 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Davis Gregory D Head of Research & Technology | 0 | $0 | 380,002 (Direct) | View |
| 2024-08-24 Tax Withholding | 2024-08-27 4:38 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 2,801 | $0.86 | 830,001 (Direct) | View |
| 2024-08-24 Tax Withholding | 2024-08-27 4:38 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH | 1,196 | $0.86 | 193,923 (Direct) | View |
| 2024-08-24 Tax Withholding | 2024-08-27 4:37 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 3,158 | $0.86 | 827,370 (Direct) | View |
| 2024-08-24 Tax Withholding | 2024-08-27 4:37 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 3,295 | $0.86 | 844,598 (Direct) | View |
| 2024-08-24 Tax Withholding | 2024-08-27 4:36 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 12,753 | $0.86 | 2,526,698 (Direct) | View |
| 2024-08-13 Tax Withholding | 2024-08-15 4:34 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 892 | $0.9751 | 832,802 (Direct) | View |
| 2024-06-11 Tax Withholding | 2024-06-13 4:42 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 892 | $0.6077 | 830,528 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:26 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director | 75,000 | $0 | 127,100 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:25 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director | 75,000 | $0 | 137,600 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:25 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 75,000 | $0 | 124,600 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:24 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Markels John Director | 75,000 | $0 | 121,384 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:24 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director | 75,000 | $0 | 107,650 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:23 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director | 75,000 | $0 | 124,600 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:23 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director | 75,000 | $0 | 124,600 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 4:23 pm | N/A 2034-06-03 | SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director | 75,000 | $0 | 107,650 (Direct) | View |
| 2024-05-24 Tax Withholding | 2024-05-29 5:18 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 3,295 | $0.6 | 842,893 (Direct) | View |
| 2024-05-24 Tax Withholding | 2024-05-29 5:15 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 2,736 | $0.6 | 833,694 (Direct) | View |
| 2024-05-24 Tax Withholding | 2024-05-29 5:00 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH | 1,195 | $0.6 | 195,119 (Direct) | View |
| 2024-05-24 Tax Withholding | 2024-05-29 4:57 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 3,158 | $0.6 | 831,420 (Direct) | View |
| 2024-05-24 Tax Withholding | 2024-05-29 4:54 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 12,753 | $0.6 | 2,539,451 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:14 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH | 4,668 | $1.13 | 196,314 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 7,832 | $1.13 | 836,430 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 10,484 | $1.13 | 846,188 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:12 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 8,927 | $1.13 | 834,578 (Direct) | View |